国际皮肤性病学杂志    0  (): 358-360   ISSN: 2096-5540  CN: 32-1880/R   系统性红斑狼疮预后的影响因素 马立娟, 刘贞富 华中科技大学同济医学院附属协和医院皮肤科 武汉 430022 收稿日期 2005-03-14  修回日期 null  网络版发布日期 null 参考文献  [1] Borchers AT, Keen CL, Shoenfeld Y, et al. Surviving the butterfly and the wolf:mortality trends in systemic lupus erythematosus. Autoimmun Rev, 2004, 3:423-453. [2] Wongchinsri J, Tantawichien T, Osiri M, et al. Infection in Thai pa tients with systemic lupus erythematosus:a review of hospitalized patients. J Med Assoc Thai, 2002, 85(Suppl 1):S34-S39. [3] Djukanovic L, Pavlovic S, Blagojevic R, et al. Lupus nephritis:retrospective analysis of the course of the disease. Srp Arh Celok Lek, 2002, 130(Suppl 3):26-31. [4] Fiehn C, Hajjar Y, Mueller K, et al. Improved clinical outcome of lupus nephritis during the past decade:importance of early diagnosis and treatment. Ann Rheum Dis, 2003, 62:435-439. [5] Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 2001, 57:496-500. [6] Karassa FB, Ioannidis JP, Boki KA, et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med, 2000, 109:628-634. [7] Bjornadal L, Yin L, Granath F, et al. Cardiovascular disease a haz ard despite improved prognosis in patients with systemic lupus erythematosus:results from a Swedish population based study 1964-95.J Rheumatol, 2004, 31:713-719. [8] Julkunen H, Miettinen A, Walle TK, et al. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block:a population based study. J Rheumatol, 2004, 31:183-189. [9] Fluture A, Chaudhari S, Frishman WH. Valvular heart disease and systemic lupus erythematosus:therapeutic implications. Heart Dis, 2003, 5:349-353. [10] Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford), 2000, 39:399-406. [11] Haas C.Pulmonary hypertension associated with systemic lupus ery thematosus. Bull Acad Natl Med, 2004, 188:985-997. [12] Karim MY, Miranda LC, Tench CM, et al. Presentation and progno sis of the shrinking lung syndrome in systemic lupus erythematosus.Semin Arthritis Rheum, 2002, 31:289-298. [13] Smolen JS. Therapy of systemic lupus erythematosus:a look into the future. Arthritis Res, 2002, 4(Suppl 3):S25-S30. [14] Bricou O, Taieb O, Baubet T, et al. Stress and coping strategies in systemic lupus erythematosus. Presse Med, 2004, 33:1284-1292. [15] Uribe AG, Alarcon GS, Sanchez ML, et al. Systemic lupus erythematosus in three ethnic groups. ⅩⅧ. Factors predictive of poor compliance with study visits. Arthritis Rheum, 2004, 51:258-263. [16] Meyer O. Making pregnancy safer for patients with lupus. Joint Bone Spine, 2004, 71:178-182. [17] Tandon A, Ibanez D, Gladman DD, et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum, 2004, 50:3941-3946. [18] Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol, 2002, 16:847-858. [19] Miettunen PM, Ortiz-Alvarez O, Petty RE, et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol, 2004, 31:1650-1654. 通讯作者: